298 related articles for article (PubMed ID: 25847131)
1. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation.
Hanson SJ; Havens PL; Simpson PM; Nugent ML; Wells RG
Pediatr Pulmonol; 2015 Dec; 50(12):1328-35. PubMed ID: 25847131
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.
Wells RG; Havens PL
Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898
[TBL] [Abstract][Full Text] [Related]
3. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural alteplase in a patient with complicated pleural effusion.
Walker CA; Shirk MB; Tschampel MM; Visconti JA
Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
Pediatrics; 2004 Mar; 113(3 Pt 1):e182-5. PubMed ID: 14993574
[TBL] [Abstract][Full Text] [Related]
6. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of large-dose intrapleural alteplase for complicated pediatric parapneumonic effusion and empyema.
Taylor JL; Liu M; Hoff DS
J Pediatr Pharmacol Ther; 2015; 20(2):128-37. PubMed ID: 25964730
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion.
James CA; Lewis PS; Moore MB; Wong K; Rader EK; Roberson PK; Ghaleb NA; Jensen HK; Pezeshkmehr AH; Stroud MH; Ashton DJ
Pediatr Radiol; 2022 Nov; 52(12):2413-2420. PubMed ID: 35451632
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema.
Cochran JB; Tecklenburg FW; Turner RB
Pediatr Crit Care Med; 2003 Jan; 4(1):39-43. PubMed ID: 12656540
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.
Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
Am J Respir Crit Care Med; 1999 Jan; 159(1):37-42. PubMed ID: 9872815
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.
Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M
Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208
[TBL] [Abstract][Full Text] [Related]
13. Urokinase in the management of complicated parapneumonic effusions in children.
Krishnan S; Amin N; Dozor AJ; Stringel G
Chest; 1997 Dec; 112(6):1579-83. PubMed ID: 9404757
[TBL] [Abstract][Full Text] [Related]
14. Medical management of parapneumonic pleural disease.
Barnes NP; Hull J; Thomson AH
Pediatr Pulmonol; 2005 Feb; 39(2):127-34. PubMed ID: 15573391
[TBL] [Abstract][Full Text] [Related]
15. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema.
Huang HC; Chang HY; Chen CW; Lee CH; Hsiue TR
Chest; 1999 Mar; 115(3):751-6. PubMed ID: 10084488
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural Thrombolytics for Parapneumonic Effusion: A Network Metaanalysis.
Sridharan K; Sivaramakrishnan G
Curr Rev Clin Exp Pharmacol; 2024; 19(2):204-212. PubMed ID: 36173062
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural streptokinase for empyema and complicated parapneumonic effusions.
Diacon AH; Theron J; Schuurmans MM; Van de Wal BW; Bolliger CT
Am J Respir Crit Care Med; 2004 Jul; 170(1):49-53. PubMed ID: 15044206
[TBL] [Abstract][Full Text] [Related]
19. Parapneumonic pleural effusion and empyema.
Koegelenberg CF; Diacon AH; Bolliger CT
Respiration; 2008; 75(3):241-50. PubMed ID: 18367849
[TBL] [Abstract][Full Text] [Related]
20. Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study.
Segerer FJ; Seeger K; Maier A; Hagemann C; Schoen C; van der Linden M; Streng A; Rose MA; Liese JG
Pediatr Pulmonol; 2017 Apr; 52(4):540-547. PubMed ID: 27648553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
